Amylase Test
by Em Diagnostic Systems, Inc.
510(k) K923677
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK923677 | Date9 Sep 1992 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JFJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1070
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Amylase Test is a device intended to measure the activity of the enzyme amylase in serum and urine. These measurements are used primarily for the diagnosis and treatment of pancreatitis, which is an inflammation of the pancreas.
This device is classified as a Class II catalytic method for amylase under regulation number 862.1070. It received FDA 510(k) clearance on September 9, 1992, under submission K923677.
Other devices from Em Diagnostic Systems, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the primary clinical purpose of the Amylase Test?
This device is designed to measure the activity of the enzyme amylase within serum and urine samples. These measurements are used by clinicians primarily to aid in the diagnosis and management of pancreatitis, which is an inflammation of the pancreas.
How is this device classified for regulatory purposes?
The Amylase Test is classified as a Class II catalytic method for amylase under regulation number 862.1070. It received FDA 510(k) clearance on September 9, 1992, under submission number K923677.
Which medical specialty oversees this diagnostic test?
The device falls under the Clinical Chemistry medical specialty. This classification is based on its function as a catalytic method for measuring enzyme activity in biological fluids.